HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Il Jun Kang Selected Research

Cognitive Dysfunction

12/2021Ischemia-Induced Cognitive Impairment Is Improved via Remyelination and Restoration of Synaptic Density in the Hippocampus after Treatment with COG-Up® in a Gerbil Model of Ischemic Stroke.
12/2018Melatonin improves vascular cognitive impairment induced by ischemic stroke by remyelination via activation of ERK1/2 signaling and restoration of glutamatergic synapses in the gerbil hippocampus.
4/2018Melatonin attenuates scopolamine-induced cognitive impairment via protecting against demyelination through BDNF-TrkB signaling in the mouse dentate gyrus.
1/2018Effects of chronic scopolamine treatment on cognitive impairment and neurofilament expression in the mouse hippocampus.
1/2018Vanillin improves scopolamine‑induced memory impairment through restoration of ID1 expression in the mouse hippocampus.
1/2018Long-term treadmill exercise improves memory impairment through restoration of decreased synaptic adhesion molecule 1/2/3 induced by transient cerebral ischemia in the aged gerbil hippocampus.
1/2018Early IV-injected human dermis-derived mesenchymal stem cells after transient global cerebral ischemia do not pass through damaged blood-brain barrier.
8/2016Effects of Chronic Scopolamine Treatment on Cognitive Impairments and Myelin Basic Protein Expression in the Mouse Hippocampus.
1/2016New GABAergic Neurogenesis in the Hippocampal CA1 Region of a Gerbil Model of Long-Term Survival after Transient Cerebral Ischemic Injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Il Jun Kang Research Topics

Disease

22Ischemia
04/2024 - 09/2015
14Brain Ischemia (Cerebral Ischemia)
04/2024 - 02/2016
13Transient Ischemic Attack
10/2019 - 09/2015
9Cognitive Dysfunction
12/2021 - 01/2016
6Reperfusion Injury
05/2023 - 06/2019
5Gliosis
03/2024 - 08/2017
3Brain Injuries (Brain Injury)
05/2023 - 01/2018
2Neuroinflammatory Diseases
04/2024 - 03/2024
2Heart Arrest (Cardiac Arrest)
12/2022 - 10/2019
2Asphyxia (Suffocation)
12/2022 - 12/2017
2Ischemic Stroke
12/2021 - 12/2018
2Hyperthermia
01/2021 - 09/2017
2Alzheimer Disease (Alzheimer's Disease)
04/2018 - 01/2018
2Neurodegenerative Diseases (Neurodegenerative Disease)
04/2018 - 02/2017
2Amnesia (Dissociative Amnesia)
04/2018 - 01/2018
1Atopic Dermatitis (Atopic Eczema)
10/2022
1Dermatitis
10/2022
1Hypothermia
12/2021
1Nervous System Diseases (Neurological Disorders)
12/2018
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
12/2018
1Lennox Gastaut Syndrome
04/2018
1Demyelinating Diseases (Demyelinating Disease)
04/2018
1Memory Disorders (Memory Loss)
01/2018
1Hypoxia (Hypoxemia)
11/2017
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2017
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2017

Drug/Important Bio-Agent (IBA)

15Neuroprotective AgentsIBA
04/2024 - 11/2015
7AntioxidantsIBA
12/2022 - 11/2015
6Proteins (Proteins, Gene)FDA Link
03/2024 - 01/2016
6salicylhydroxamic acid (SHAM)IBA
01/2021 - 09/2015
6Scopolamine (Hyoscine)FDA Link
04/2018 - 08/2016
5EnzymesIBA
12/2022 - 02/2017
4Glial Fibrillary Acidic ProteinIBA
03/2024 - 08/2017
4CytokinesIBA
10/2022 - 09/2015
4Myelin Basic ProteinIBA
12/2021 - 01/2016
4MelatoninIBA
10/2019 - 01/2018
4Brain-Derived Neurotrophic Factor (BDNF)IBA
06/2019 - 01/2016
3CalciumIBA
03/2024 - 08/2017
3Anticonvulsants (Antiepileptic Drugs)IBA
12/2022 - 04/2018
3fluoro jadeIBA
12/2021 - 04/2016
3Superoxide DismutaseIBA
03/2021 - 07/2017
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 09/2015
2aucubinIBA
03/2024 - 05/2023
2Oxcarbazepine (Trileptal)FDA LinkGeneric
12/2022 - 12/2021
2cresyl violetIBA
12/2021 - 04/2016
2scutellarinIBA
12/2021 - 03/2021
2NMDA receptor A1IBA
01/2021 - 01/2017
2Interleukin-4 (Interleukin 4)IBA
09/2019 - 09/2015
2CatalaseIBA
12/2018 - 07/2017
2Fenofibrate (CiL)FDA LinkGeneric
07/2017 - 02/2016
2Glutathione PeroxidaseIBA
07/2017 - 11/2015
2Interleukin-13IBA
02/2016 - 09/2015
1InflammasomesIBA
04/2024
1porphyranIBA
04/2024
1GlycosidesIBA
03/2024
1IridoidsIBA
03/2024
1Carbamazepine (Tegretol)FDA LinkGeneric
12/2022
1Vecuronium Bromide (Vecuronium)FDA LinkGeneric
12/2022
1laminaranIBA
10/2022
1Immunoglobulin E (IgE)IBA
10/2022
1OxazoloneIBA
10/2022
1Transient Receptor Potential ChannelsIBA
12/2021
1sinapinic acidIBA
12/2021
1Vesicular Glutamate Transport Protein 1IBA
12/2021
1ZincIBA
03/2021
1Chlorogenic AcidIBA
03/2021
1CopperIBA
03/2021
1Plant ExtractsIBA
03/2021
1Protective AgentsIBA
03/2021
1Calbindin 1IBA
01/2021
1Immunoglobulin G (IgG)IBA
01/2021
1Cyclin-Dependent Kinase 5IBA
10/2019
1Insulin-Like Growth Factor I (IGF-1)IBA
06/2019
1Nerve Growth Factors (Neurotrophins)IBA
06/2019
1rufinamideFDA Link
04/2018
1Type II Tumor Necrosis Factor ReceptorsIBA
01/2018
1vanillinIBA
01/2018
1Cholinergic Agents (Cholinergics)IBA
01/2018
1Cell Adhesion MoleculesIBA
01/2018
1hydroquinone (Esoterica)FDA Link
12/2017
1Ethanol (Ethyl Alcohol)IBA
12/2017
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017
1NF-kappa B (NF-kB)IBA
11/2017
1CalbindinsIBA
09/2017
1Superoxide Dismutase-1IBA
08/2017
1Becaplermin (PDGF-BB)FDA Link
08/2017
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2017
1AlbuminsIBA
07/2017
1Blood Proteins (Serum Proteins)IBA
07/2017
1QuercetinIBA
02/2017
1FlavonoidsIBA
02/2017
1peflavitIBA
02/2017
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2017

Therapy/Procedure

1Topical Administration
10/2022
1Induced Hypothermia
12/2021
1Aftercare (After-Treatment)
12/2021
1Cardiopulmonary Resuscitation (CPR)
10/2019
1Transplantation
01/2018
1Therapeutics
12/2017
1Induced Heart Arrest (Cardioplegia)
12/2017